Spatiotemporal clustering of state-level opioid, opioid-stimulant, and opioid-benzodiazepine polysubstance deaths across the U.S.: Hierarchical agglomerative clustering analysis
Authors:
- 11 March 2026
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 283, 113117
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse (K01DA062726)
- National Institute on Drug Abuse (L60DA061545)
- National Institute on Drug Abuse (R01DA059376)
- National Institute on Drug Abuse (T32DA031099)
- Columbia University (SF-169)
This publication has 17 references indexed in Scilit:
- Leveraging spatiotemporal Bayesian analysis to unravel polysubstance use and overdose risk: Opportunities and challengesPreventive Medicine Reports, 2025
- The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysisHarm Reduction Journal, 2024
- Geography of poly-substance drug mortalityJournal of Criminal Justice, 2023
- Climate Change and Substance-Use Behaviors: A Risk-Pathways FrameworkPerspectives on Psychological Science, 2022
- What’s in fake “Xanax”? : a dosage survey of designer benzodiazepines in counterfeit pharmaceutical tabletsDrug Testing and Analysis, 2021
- The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisisCurrent Opinion in Psychiatry, 2021
- Fentanyl shock: The changing geography of overdose in the United StatesInternational Journal of Drug Policy, 2019
- Twin epidemics: The surging rise of methamphetamine use in chronic opioid usersDrug and Alcohol Dependence, 2018
- Pharmaceutical Overdose Deaths, United States, 2010JAMA, 2013
- The ‘risk environment’: a framework for understanding and reducing drug-related harmInternational Journal of Drug Policy, 2002